ARCHIVES

ODAC Rejects Temodal for Melanoma After Discussion Of Approval Standards

This article is from The Cancer Letter archive.

Vol. 25 No. 13 | April 2, 1999

Download PDF Visit The Full Archive

Related Articles

NIH Proposes Center for Cell Biology

February 19, 1993

Larynx Preservation Provides Better Voice Quality For Patients

February 29, 2008

Growth Of The Cost of Drugs Slows to 5.4 Percent per Year; 21 Therapies Launched in 2 Years

May 9, 2014

FDA Approves Gleevec In 73 Days, A Speed Record.

May 18, 2001

Radiologists Dispute Holland On NMR

April 20, 1984

Provenge Prolonged Prostate Cancer Survival By Seven Months, Study Finds

September 26, 2003